Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
NCT04961450 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 2500
Last updated 2021-07-14
Summary
1. To investigate the biomarkers of MND/FTD spectrum disease
2. To explore the possible pathogenesis of MND/FTD
Conditions
- Amyotrophic Lateral Sclerosis
- Frontotemporal Dementia
- Motor Neuron Disease
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-24
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- China
Study Locations
More Related Trials
-
Neurodegenerative Diseases Registry
NCT04472130 ·Status: UNKNOWN
-
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
NCT06561906 ·Status: RECRUITING
-
Blood Biomarkers for Screening of Alzheimer's Disease
NCT06477484 ·Status: RECRUITING
-
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
NCT06856850 ·Status: RECRUITING
-
Magnetic Resonance Imaging-based Comparative Research in Different Mild Cognitive Impairment Subtype
NCT02706210 ·Status: UNKNOWN
-
Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages
NCT06516016 ·Status: NOT_YET_RECRUITING
-
Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders
NCT04926259 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Application of Multi-probe PET/MR Imaging in the Diagnosis and Evaluation of Alzheimer's Disease
NCT05003830 ·Status: UNKNOWN
-
Clinical Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients
NCT05043675 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Evolution and Prognosis of Moyamoya Disease
NCT05619068 ·Status: RECRUITING
-
Methods of Etiological Diagnosis of Cerebral Amyloid Angiopathy
NCT02361411 ·Status: UNKNOWN
-
Identifying New Biomarkers of Parkinson's From Routine Brain Imaging
NCT04986020 ·Status: UNKNOWN
-
Biomarker Study to Diagnose Alzheimer's Disease
NCT01874418 ·Status: UNKNOWN ·Phase: NA
-
Multimodal Biomarkers for Diagnosis and Prognosis in VCI
NCT04604600 ·Status: UNKNOWN ·Phase: PHASE3
-
Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases
NCT05260151 ·Status: UNKNOWN
-
Multimodal Biomarkers for Diagnosis and Prognosis in CAA
NCT03969732 ·Status: UNKNOWN ·Phase: PHASE3
-
[18F]APN-1607 PET in Subjects With AD Compared to HC
NCT05542953 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study
NCT04850001 ·Status: RECRUITING
-
Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion
NCT02353884 ·Status: COMPLETED
-
Multi-modality MRI Study on Differences in Conversion of aMCI Patients With APOEε4 to AD
NCT02225964 ·Status: COMPLETED
-
MRI Maker of Perioperative Neurocognitive Disorder
NCT03773627 ·Status: UNKNOWN
-
EEG Motor Movement and Imagery Dataset for Stroke
NCT05499442 ·Status: UNKNOWN
-
[18F]AV45(Aβ) and [18F]AV1451(Tau)PET/CT in the Diagnosis of Early Pathological Changes of Alzheimer's Disease
NCT06833645 ·Status: RECRUITING
-
Molecular and Functional Imaging in Monogenic PD.
NCT05518617 ·Status: RECRUITING
-
Study on Biomarkers for Early Diagnosis of Alzheimer's Disease
NCT04575337 ·Status: RECRUITING